Kallmann Syndrome (KS) is a genetically heterogenous disease with the most defining features of hypogonatrophic hypogonadism and anosmia, which are believed to be the result of neural targeting and migration defects. The X-linked form of this disease accounts for approximately 10% of KS cases and is caused by mutations in the anosmin-1/KAL1 gene. We have previously shown that over-expression of the Caenorhabditis elegans homolog of anosmin-1/KAL1 in AIY interneurons causes a highly penetrant, dosage-dependent, and cell autonomous axonal branching phenotype. In a modifier screen we have isolated the
ot21 enhancer mutation, which leads to significantly longer axonal branches (Bulow et al., 2002 PNAS). This enhancement is specific for the
kal-1-dependent branching phenotype in AIY because
ot21 fails to enhance the ectopic neurites elicited by mutations such as
ttx-3 and
sax-2 which cause similar phenotypes in AIY interneurons. Phenotypic analysis of
ot21 revealed axonal defects in DVB and HSN motor neurons as well as specific behavioral defects. Cloning and molecular characterization of the
ot21 mutation revealed a missense mutation in a gene important for axonal and synaptic development consistent with a potential role of
kal-1 in neural targeting.